Also known as
Testocyp
Testocyp is an alias for testosterone cypionate, a standard injectable form of testosterone. This page covers the two specific products available at SynthesisGear: Magnus and Pharmacom. Both are 10ml vials containing 250mg per unit, intended for injection. The product is listed under the Anabolic Steroid (Injectable) category.
Product Identification
This alias refers to testosterone cypionate. It is marketed and stocked at SynthesisGear as two distinct brand products: Magnus and Pharmacom. Each vial contains 250mg of the active compound. The standard formulation for both brands is a 10ml volume, which supports specific dosing schedules based on body weight and individual physiological needs.
User Considerations
A buyer choosing between Magnus and Pharmacom should consider the specific manufacturer. The active ingredient is identical, but the product source differs. Users typically run these products as part of a broader protocol to manage overall health and performance. It is essential to monitor for potential side effects such as fluid retention or lipid changes. Regular blood-work is strongly advised to track hormone levels and ensure safe usage.
Questions & answers
What are the main differences between these two brands?
The primary difference lies in the manufacturer. Magnus and Pharmacom both supply this specific product, but they differ by brand origin. The active compound is identical. Users should verify their specific source when purchasing to ensure they receive the correct item.
What is the standard dose for this injectable steroid?
The standard dose is 250mg per vial. This specific amount requires careful calculation based on individual body weight and medical history. Dosing must be strictly adhered to, as variations can significantly impact overall physiological function.
Are there any specific precautions for users of this compound?
Users must monitor their health closely. Potential side effects include changes in blood pressure and lipid profiles. Regular medical check-ups are necessary to manage these risks. Healthcare providers should be consulted regarding any pre-existing conditions.